Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Sep 10;6(3):80.
doi: 10.3390/diseases6030080.

Potential Therapeutic Benefits of Herbs and Supplements in Patients with NAFLD

Affiliations
Review

Potential Therapeutic Benefits of Herbs and Supplements in Patients with NAFLD

Brandon J Perumpail et al. Diseases. .

Abstract

Our aim is to review the efficacy of various herbs and supplements as a possible therapeutic option in the treatment and/or prevention of nonalcoholic fatty liver disease (NAFLD). We performed a systematic review of medical literature using the PubMed Database by searching the chemical names of many common herbs and supplements with "AND (NAFLD or NASH)". Studies and medical literature that discussed the roles and usage of herbs and supplements in NAFLD and nonalcoholic steatohepatitis (NASH) from inception until 20 June 2018 were reviewed. Many studies have claimed that the use of various herbs and supplements may improve disease endpoints and outcomes related to NAFLD and/or NASH. Improvement in liver function tests were noted. Amelioration or reduction of lobular inflammation, hepatic steatosis, and fibrosis were also noted. However, well-designed studies demonstrating improved clinical outcomes are lacking. Furthermore, experts remain concerned about the lack of regulation of herbs/supplements and the need for further research on potential adverse effects and herb⁻drug interactions. In conclusion, preliminary data on several herbs have demonstrated promising antioxidant, anti-inflammatory, anti-apoptotic, and anti-adipogenic properties that may help curtail the progression of NAFLD/NASH. Clinical trials testing the safety and efficacy must be completed before widespread can be recommended.

Keywords: Ginkgo biloba; NAFLD; NASH; cannabinoids; coffee; fish oil; garlic; green tea; herb; nonalcoholic fatty liver disease; resveratrol; silymarin; turmeric.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest, including financial and/or material support for the preparation of this manuscript.

Similar articles

Cited by

References

    1. Blond E., Disse E., Cuerq C., Drai J., Valette P.J., Laville M., Thivolet C., Simon C., Caussy C. Easl-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease in severely obese people: Do they lead to over-referral? Diabetologia. 2017;60:1218–1222. doi: 10.1007/s00125-017-4264-9. - DOI - PubMed
    1. Chalasani N., Younossi Z., Lavine J.E., Diehl A.M., Brunt E.M., Cusi K., Charlton M., Sanyal A.J., American Gastroenterological Association. American Association for the Study of Liver Diseases et al. The diagnosis and management of non-alcoholic fatty liver disease: Practice guideline by the American gastroenterological association, American association for the study of liver diseases, and American college of gastroenterology. Gastroenterology. 2012;142:1592–1609. doi: 10.1053/j.gastro.2012.04.001. - DOI - PubMed
    1. Oseini A.M., Sanyal A.J. Therapies in non-alcoholic steatohepatitis (NASH) Liver Int. 2017;37(Suppl. 1):97–103. doi: 10.1111/liv.13302. - DOI - PMC - PubMed
    1. Liu Z.L., Xie L.Z., Zhu J., Li G.Q., Grant S.J., Liu J.P. Herbal medicines for fatty liver diseases. Cochrane Database Syst. Rev. 2013:CD009059. doi: 10.1002/14651858.CD009059.pub2. - DOI - PubMed
    1. Xiao J., Fai So K., Liong E.C., Tipoe G.L. Recent advances in the herbal treatment of non-alcoholic fatty liver disease. J. Tradit. Complement. Med. 2013;3:88–94. doi: 10.4103/2225-4110.110411. - DOI - PMC - PubMed

LinkOut - more resources